chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity
Clinical narrative: Left arm pain; Headache after waking up the following morning; Chills; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 16:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included C6/C7 spinal cord injury and lactose allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 12May2021 at 06:30, the patient experienced left arm pain, headache after waked up the following morning and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of events and included treatment with ibuprofen on an unknown date. The clinical outcome of the events left arm pain, headache after waking up the following morning and chills was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Ocular hyperaemia, Pruritus
Clinical narrative: itchiness of the eyes lids, under the eyes, eyebrows; Itchiness of forehead; Redness and burning of the eyes; Redness and burning of the eyes; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 06May2021 at 09:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06May2021, the patient experienced itchiness of the eyes lids, under the eyes, eyebrows and forehead as well as redness and burning of the eyes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events itchiness of the eyes lids, under the eyes, eyebrows and forehead as well as redness and burning of the eyes were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Myalgia, Swelling
Clinical narrative: Swelling of left armpit, soft and tender; Swelling of left armpit, soft and tender; Muscle soreness all over; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 10May2021 at 11:30 (at the age of 40-years-old) as a single dose for COVID-19 immunization. Medical history included depression. The patient had no known allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), lamotrigine (LAMICTAL); both for unknown indications and ethinyl estradiol, norgestimate (ORTHO TRI-CYCLEN) for birth control; and all from unknown dates for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 10May2021 at 11:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10May2021, at 19:00 the patient experienced swelling of left armpit, soft and tender, muscle soreness all over, exhaustion. All were still present after 48+ hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event left armpit, soft and tender, muscle soreness all over, exhaustion were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Pain, Swelling
Clinical narrative: somewhat sore; Tenderness; Pain left armpit; slight swelling; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08May2021 at 13:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medication within two weeks of vaccination. On 09May2021 at 19:00 the patient experienced tenderness, pain left armpit, and slight swelling. On 12May2021, 4 days later, the patient stated still somewhat sore not a major concern. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tenderness, pain left armpit, slight swelling and somewhat sore was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: Swollen armpit on left side filled with liquid; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10May2021 at 08:15 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient previously took doxycycline hydrochloride (DOXY) on an unknown date for unspecified indication and experienced the event rash(She think the rash was a known AE from the other med she took simultaneously). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 the patient experienced swollen armpit on left side filled with liquid and the patient was aware of this known adverse event. She just want you to have the right percentage. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as the result of events. The clinical outcome of the event swollen armpit on left side filled with liquid was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Full body hives; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 07May2021 at 14:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included paracetamol (TYLENOL) for unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 16Apr2021 at 14:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 10May2021, 3 days after second dose, the patient experienced full body hives. Since the vaccination, the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event full body hives was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Aphthous ulcer, Fatigue, Mouth swelling, Oropharyngeal pain
Clinical narrative: Multiple canker sores on tongue; Sore throat; Mouth generally swollen; Tired; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 10:30 (at the age of 29-year-old) as single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Apr2021, at 12:00, the patient experienced multiple canker sores on tongue, sore throat, mouth generally swollen and was tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of multiple canker sores on tongue, sore throat, mouth generally swollen and was tired were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Its been exactly two weeks since I received the second dose of my vaccine, and I started with chills; Its been exactly two weeks since I received the second dose of my vaccine, and I started with chills and fever, but no other symptoms.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0169) via an unspecified route of administration in the arm left on 27Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The medical history included allergy to most allergy medicines. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) via an unspecified route of administration in the arm left on 06Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient previously took pseudoephedrine hydrochloride (SUDAFED) on an unknown date and experienced allergy. On 10May2021 at 20:00, two weeks after the second dose of vaccine, the patient experienced chills and fever and no other symptoms. It was little over 24 hours and the patient was having low fever at the time of the report. The patient reported that she did not have any side effects to the vaccine the day of or the day after receiving both doses of the vaccine. The patient asked that was it possible to have delayed side effects to the vaccine or did she got sick from something else. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills and fever was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Allergy to vaccine
Clinical narrative: his wife and him were not feeling so good, due to allergies; This is a spontaneous report from a contactable consumer or other non hcp (patient).     A 52-years-old male patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated his wife and him were not feeling so good, due to allergies on an unspecified date. The caller stated that, received both doses of the Pfizer Covid-19 vaccine, but the second dose was rescheduled to be given after 5 weeks instead of 3 as his wife and him were not feeling so good, due to allergies. He wanted to know if the vaccine would be as effective if it was not given at 3 weeks. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021536037 same reporter/drug/event, different patient
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic, Urticaria
Clinical narrative: Full body rashes or hives; My arm started feeling a bit itchy; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 08May2021 at 09:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Allergies to medications, food or other products were reported as not that the patient knows of. The patient previously received first dose of BNT162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On 11May2021 at 03:00, the patient experienced full body rashes or hives. The patient was not sure which one they were. This was about 3 to 4 days after the shot. The patient's arm started feeling a bit itchy when he went to sleep that night and the next day these bumps were spreading all over. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event full body rashes or hives, started feeling a bit itchy was not resolved at the time of this report.  No follow-up attempts are needed; No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Electric shock sensation, Feeling abnormal
Clinical narrative: Brain fog; brain zaps; lightheaded; a bit of confusion; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11May2021 at 09:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included sertraline hydrochloride (ZOLOFT) 250 mg and ibuprofen (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Apr2021 at 09:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. On 12May2021 at 09:00, the patient experienced brain fog, and brain zaps. It was reported that zaps similar to when ZOLOFT dose was off but she was 100% certain, she had taken meds correctly. Also lightheaded and a bit of confusion. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, and brain zaps, zaps similar to when ZOLOFT dose was off, lightheaded and a bit of confusion was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm sore at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 15:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported.  On 12May2021 the patient experienced arm sore at the injection site. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if any therapeutic measures were taken as a result of the event. The clinical outcome of the event arm sore at the injection site was recovered with sequelae on 12May2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Ear pain, Headache
Clinical narrative: Headache; Sore Throat; Chills; Low grade fever; Achey Body; Very low energy; Nausea; Congestion; Coughing; Ears hurt; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO167) via an unspecified route of administration in the left arm on 29Apr2021 at 08:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. Medical history included heart disease. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 02:30, the patient experienced headache, sore throat, chills, low-grade fever, achy body, very low energy, nausea, congestion and coughing, and ears hurt. It was also reported that the patient honestly felt like she was dying. The patient was tested for COVID-19 post-vaccination. On 08May2021, the patient underwent a nasal swab test (COVID-19 virus test) and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events included treatment with azithromycin (Z-Pak). The clinical outcome of the events headache, sore throat, chills, low-grade fever, achy body, very low energy, nausea, congestion and coughing and ears hurt were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nausea, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: Headache; Sore Throat; Chills; Low grade fever; Achey Body; Very low energy; Nausea; Congestion; Coughing; Ears hurt; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO167) via an unspecified route of administration in the left arm on 29Apr2021 at 08:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. Medical history included heart disease. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 02:30, the patient experienced headache, sore throat, chills, low-grade fever, achy body, very low energy, nausea, congestion and coughing, and ears hurt. It was also reported that the patient honestly felt like she was dying. The patient was tested for COVID-19 post-vaccination. On 08May2021, the patient underwent a nasal swab test (COVID-19 virus test) and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events included treatment with azithromycin (Z-Pak). The clinical outcome of the events headache, sore throat, chills, low-grade fever, achy body, very low energy, nausea, congestion and coughing and ears hurt were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Headache; Sore Throat; Chills; Low grade fever; Achey Body; Very low energy; Nausea; Congestion; Coughing; Ears hurt; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO167) via an unspecified route of administration in the left arm on 29Apr2021 at 08:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. Medical history included heart disease. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 02:30, the patient experienced headache, sore throat, chills, low-grade fever, achy body, very low energy, nausea, congestion and coughing, and ears hurt. It was also reported that the patient honestly felt like she was dying. The patient was tested for COVID-19 post-vaccination. On 08May2021, the patient underwent a nasal swab test (COVID-19 virus test) and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events included treatment with azithromycin (Z-Pak). The clinical outcome of the events headache, sore throat, chills, low-grade fever, achy body, very low energy, nausea, congestion and coughing and ears hurt were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Pain throughout body; I have been feeling fatigue; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO167) via an unspecified route of administration in the right arm on 30Apr2021 at 10:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included hashimotos. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO158) via an unspecified route of administration in the left arm on 09Apr2021 at 10:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. On 01May2021, the patient was feeling fatigue and pain throughout body since vaccine. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events feeling fatigue and pain throughout body since vaccine was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination site pain
Clinical narrative: Mild pain/discomfort in arm, close to the injection point; persistent.; Mild pain/discomfort in arm, close to the injection point; persistent.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 15:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included bladder cancer remission and atrial flutter. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 14:00, the patient experienced mild pain/discomfort in arm, close to the injection point which was persistent. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild pain/discomfort in arm, close to the injection point was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles rash; This is a spontaneous report from a contactable other healthcare professional, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 26Apr2021 at 13:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to vaccination. Concomitant medications were not reported. On 01May2021 at 11:00, 5 days post vaccine, the patient had experienced shingles rash. The event had resulted in doctors or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of event which included treatment with valacyclovir (MANUFACTURER UNKNOWN). The clinical outcome of the event shingles rash was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Ear discomfort
Clinical narrative: Feeling of fluid in left ear; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 10May2021 at 08:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received tetracycline (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received  the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 12Apr2021 at 08:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. On 11May2021 at 07:00,  morning after receiving the second vaccine, the patient felt fluid in left ear which had continued to persist for a second day, even though the patient tried sleeping on left ear to help it to drain. The patient did not have the feeling of fluid in his ears for as long as he could remember. Since the vaccination, the patient had not been tested for COVID-19.  No therapeutic measures were taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event felt fluid in left ear which was continued to persist for a second day was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine
Clinical narrative: His wife and him were not feeling so good, due to allergies; This is a spontaneous report from a contactable consumer or other non hcp. A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: Not reported), via an unspecified route of administration on an unspecified date (at the age of 49-Year-old) as dose 1, single for COVID-19 immunization. The second dose was rescheduled to be given after 5 weeks instead of 3. The patient medical history and concomitant medications were not reported. The patient experienced not feeling so good, due to allergies on an unspecified date. Patient husband would like to know if the vaccine would be as effective if it was not given at 3 weeks. The outcome of the event was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021535334 same reporter/drug/event, different patient
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Joint pain; Muscle aches; tiredness; This is a spontaneous report from a contactable nurse. A 21-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0193) via an unspecified route of administration in the left arm on an unknown date (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient was allergic to penicillin. It was unknown whether the patient was pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on an 20Apr2021 at 16:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 00:00, the patient experienced fever, chills, joint pain, muscle aches and tiredness with the second dose. The patient reported to have experienced no symptoms with the first dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events ever, chills, joint pain, muscle aches and tiredness were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching on torso for 3 weeks now; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 14Apr2021 at 09:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient received other medications within two weeks of COVID-19 vaccine, names were unspecified. The patient previously took acetylsalicylic acid (ASPIRIN) from an unknown date for an unspecified indication and experienced drug allergy. On 14Apr2021, the patient experienced "itching on torso for 3 weeks now". The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event "itching on torso for 3 weeks now" was not recovered at the time of this report. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the right arm on 05May2021 at 09:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Enlarged lymph glands under left arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN2600) via an unspecified route of administration in the left arm on 16Feb2021 at 15:00 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, hypothyroidism, cardiovascular disease and asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT HFA), levothyroxine (MANUFACTURER UNKNOWN), hydrochlorothiazide (THIAZIDE) and me (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications and unknown if ongoing. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) on an unknown date for unknown indication and experienced drug allergy and received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via an unspecified route of administration in the left arm on 26Jan2021 at 12:15 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Feb2021, the patient experienced enlarged lymph glands under left arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for enlarged lymph glands under left arm. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event enlarged lymph glands under left arm was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia
Clinical narrative: Low fever; Swollen lymph nodes under left arm and left clavicle; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 10May2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. It was unknown whether the patient had any known allergies to medications, food or other products. Concomitant medications included hydroxyzine (MANUFACTURER UNKNOWN), unspecified medication for birth control (MANUFACTURER UNKNOWN), vitamins (MANUFACTURER UNKNOWN) and probiotics (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 19Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021 at 20:00, the patient experienced low fever and swollen lymph nodes under left arm and left clavicle. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events low fever and swollen lymph nodes under left arm and left clavicle were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Body aches; Fever; Chills; Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 17:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient had unspecified allergies. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN) and omeprazole (MANUFACTURER UNKNOWN), both taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 11:30, the patient experienced body aches, fever, chills and pain at injection site. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care.  Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, fever, chills and pain at injection site were not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness, Fatigue, Flushing, Headache
Clinical narrative: Congestion; Flush; Low grade fever; Headache; Upset stomach; Dizzy - comes and goes; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 13:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergy to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) on an unknown date, for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 09:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12May2021 at 00:00, the patient experienced congestion, flush, low grade fever, headache, upset stomach, dizzy that comes and goes and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events congestion, flush, low grade fever, headache, upset stomach, dizzy - comes and goes and fatigue were not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Pyrexia
Clinical narrative: Congestion; Flush; Low grade fever; Headache; Upset stomach; Dizzy - comes and goes; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11May2021 at 13:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergy to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) on an unknown date, for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 09:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12May2021 at 00:00, the patient experienced congestion, flush, low grade fever, headache, upset stomach, dizzy that comes and goes and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events congestion, flush, low grade fever, headache, upset stomach, dizzy - comes and goes and fatigue were not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lethargy, Pain, Testicular pain
Clinical narrative: Intense aching in left testicle that began within an hour of receiving dose 2 of the vaccine; body aches; lethargy; headache; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 05May2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included Calcium/magnesium/zinc supplements and cannabis sativa (CANNABIS); all taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 14Apr2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 16:30, the patient experienced intense aching in left testicle that began within an hour of receiving dose 2 of the vaccine and lasted for roughly three days, The intensity of the pain fluctuated from 3/10 to 7/10, coming and going throughout the day, decreasing in frequency until it all but ceased on day 4. Since then he has had reoccurrences of the pain; however, they were momentary and few and far between maybe once or twice a day. His other side effects were normal headache, body aches and lethargy. The occurrences of testicular pain decreased alongside his other symptoms. The patient did not seek care because the experience seemed to correlate with the vaccine, and he thought it wise to wait it out. He did not or was not aware of having a pre-existing condition or testicular illness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense aching in left testicle that began within an hour of receiving dose 2 of the vaccine, body aches, lethargy and headache was resolving  at the time of this report.   No follow-up attempts are needed. No further information is expected.